Jun 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Jun 8, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Extended Duration Parenteral Products as Patient Adherence Strategies For a number of years, extended-release parenteral formulations have garnered enormous attention due to their effective drug concentrations over extended periods and improve patient compliance...
Recent Comments